High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma

Purpose We evaluated the role of FDG-PET/CT in patients with metastatic gastric adenocarcinoma before palliative chemotherapy to predict prognosis and chemotherapeutic response. Methods The study included 35 consecutive newly diagnosed patients with metastatic gastric adenocarcinoma who underwent FD...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cancer research and clinical oncology 2010-12, Vol.136 (12), p.1929-1935
Hauptverfasser:	Chung, Hyun Woo, Lee, Eun Jeong, Cho, Yo-Han, Yoon, So Young, So, Young, Kim, Sung-Yong, Lee, Mark Hong, Kim, Jeong Hwan, Lee, Sun-Young, Sung, In-Kyung, Park, Hyung-Seok, Yoo, Moon-Won, Lee, Kyung-Yung
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - diagnosis Adenocarcinoma - drug therapy Adult Aged Aged, 80 and over Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Cancer Cancer Research FDG Female Fluorodeoxyglucose F18 - pharmacokinetics Follow-Up Studies Gastroenterology. Liver. Pancreas. Abdomen Gastrointestinal diseases Hematology Humans Internal Medicine Kaplan-Meier Estimate Male Medical prognosis Medical sciences Medicine Medicine & Public Health Metastasis Metastatic gastric adenocarcinoma Middle Aged Neoplasm Metastasis Oncology Original Paper Palliative Care - methods Palliative Care - statistics & numerical data PET/CT Pharmacology. Drug treatments Positron-Emission Tomography - methods prognosis Proportional Hazards Models Reproducibility of Results Sensitivity and Specificity Stomach Neoplasms - diagnosis Stomach Neoplasms - drug therapy Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tomography Tomography, X-Ray Computed - methods Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!